Erythrocytosis - Causes, Treatment & When to See a Doctor

What is Erythrocytosis?

Erythrocytosis, also known as polycythemia, refers to an abnormal increase in red blood cells (RBCs) in the bloodstream. Red blood cells are responsible for carrying oxygen from the lungs to tissues throughout the body. While a higher-than-normal RBC count can improve oxygen delivery, excessive levels can thicken the blood, raising the risk of clots, strokes, or heart problems. Erythrocytosis is broadly classified into two types:

• Absolute erythrocytosis: An actual increase in RBC count, which may result from overproduction in the bone marrow or excess RBCs circulating in the blood.
• Relative erythrocytosis: A lower than normal plasma volume, which concentrates RBCs without increasing their total number.

This condition may be primary (caused by a bone marrow disorder like polycythemia vera) or secondary (triggered by external factors like low oxygen levels). Understanding the cause is critical for effective treatment. For more details, refer to the Mayo Clinic.

Common Causes

Erythrocytosis can arise from various underlying conditions. Below are 10 common causes, as outlined by the Cleveland Clinic and NIH:

Primary Causes

• Polycythemia Vera (PV): A rare blood cancer where the bone marrow produces too many RBCs due to a genetic mutation (JAK2).
• Chronic Lung Disease: Conditions like COPD or pulmonary fibrosis reduce oxygen levels, prompting the body to produce more RBCs.
• Sleep Apnea: Poor oxygen intake during sleep can lead to elevated RBC counts.
• Kidney Disease: Kidney tumors or cysts may secrete excess erythropoietin (a hormone that stimulates RBC production).

Secondary Causes

• High Altitude: Living above 8,000 feet can reduce oxygen availability, stimulating RBC production.
• Heart Disease: Conditions that impair oxygen delivery, such as congestive heart failure, may trigger erythrocytosis.
• Certain Medications: Drugs like oral contraceptives, corticosteroids, or anabolic steroids can increase RBC levels.
• Dehydration or Blood Loss: Reduced plasma volume causes relative erythrocytosis.
• Illegal Drug Use: Cocaine or opioid abuse may mimic erythrocytosis by increasing RBC production.
• Smoking: Nicotine exposure causes vasoconstriction, reducing oxygen delivery and prompting RBC overproduction.

Associated Symptoms

Symptoms of erythrocytosis often stem from thicker blood, reduced oxygen flow, or complications like clots. Common symptoms include:

• Headaches: Caused by elevated blood pressure or reduced cerebral oxygenation.
• Fatigue: Ironically, despite higher RBCs, tissues may not receive enough oxygen.
• Dizziness or Lightheadedness: Reduced blood flow to the brain.
• Shortness of Breath: Due to blood viscosity impairing circulation.
• Unexplained Redness: Skin or sclera (whites of eyes) may appear flushed.
• Nosebleeds: Thickened blood increases bleeding risk.
• Chest Pain: A sign of potential blood clots or heart strain.

Severe cases may present with bluish lips (cyanosis) or transient ischemic attacks (TIAs). Consult the WHO for further guidance on symptom management.

When to See a Doctor

Seek immediate medical attention if you experience:

• Severe headaches or vision changes.
• Chest pain or palpitations.
• Weakness or numbness in limbs (signs of a stroke or clot).
• Frequent nosebleeds or bleeding gums.

Even mild, persistent symptoms like headaches or fatigue should be evaluated by a healthcare provider. Early diagnosis can prevent complications, as emphasized by the CDC.

Diagnosis

Diagnosing erythrocytosis involves a combination of blood tests and clinical evaluation. Key diagnostic tools include:

Initial Blood Tests

• Complete Blood Count (CBC): Measures RBC count, hematocrit, and hemoglobin levels. A hematocrit >52% in men or >48% in women may indicate erythrocytosis.
• Peripheral Blood Smear: Examines RBC shape and_other cell types to rule out anemia or other disorders.
• Erythropoietin Levels: High levels suggest secondary erythrocytosis (e.g., due to kidney disease).

Additional Tests

• Bone Marrow Biopsy: Confirms PV or other myeloproliferative disorders.
• imaging (e.g., CT/MRI): Identifies tumors or structural abnormalities causing secondary erythrocytosis.
• Oxygen Saturation Testing: Measures blood oxygen levels to assess for hypoxia (low oxygen).

For detailed diagnostic criteria, refer to the NIH guidelines.

Treatment Options

Treatment depends on the underlying cause. Below are options recommended by the Cleveland Clinic and Mayo Clinic:

Medical Treatments

• Phlebotomy: Regular blood removal to reduce RBC count and blood viscosity.
• Hydroxyurea: A chemotherapy drug that lowers RBC production.
• Aspirin: Reduces blood clot risk in patients with PV.
• Oxygen Therapy: For secondary erythrocytosis caused by low oxygen levels.

Lifestyle and Home Treatments

• Hydration: Drinking enough water helps maintain plasma volume.
• Smoking Cessation: Critical for reducing relative erythrocytosis.
• Avoiding Alcohol: Alcohol can worsen dehydration and anemia.

Prevention Tips

While not all cases of erythrocytosis are preventable, these strategies may reduce risk, per the CDC:

• Stay Hydrated: Especially at high altitudes.
• Limit Exposure to Hypoxia: Avoid unnecessary high-altitude travel if at risk.
• Manage Chronic Conditions: Control lung or heart disease to prevent secondary erythrocytosis.
• Avoid Stimulants: Quit smoking and avoid drug use.

Emergency Warning Signs

Remember, this information is not a substitute for professional medical advice. Always consult a licensed healthcare provider for diagnosis and treatment. Sources include the Mayo Clinic, Cleveland Clinic, and NIH.